LIBRARY OF PAST COVID-NEURO WEBINARS 


Click here to view this webinar in full screen. 

Neurological Associations of COVID-19: Thrombotic events following vaccination

18/05/21

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are frequent. In this episode, we will discuss thrombotic events following COVID-19 vaccination. We will also have a brief literature digest from @Neuropsychcovid.


Click here to view this webinar in full screen. 

Neurological Associations of COVID-19: How does SARS-CoV-2 affect the brain in mild and severe disease?

20/04/21

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are frequent. In this episode, Dr Clarissa Lin Yasuda will talk about how SARS-CoV-2 impairs neuronal viability and Prof Paul Harrison will talk about his research on bidirectional associations between COVID-19 and psychiatric disorder published in Lancet Psychiatry. We will also have a brief literature digest from @Neuropsychcovid. 


Click here to view this webinar in full screen. 

Neurological Associations of COVID-19: COVID and the brain in Britain and Brazil

16/03/2021

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are frequent. In this episode, Dr Lúcia Brito will discuss mechanisms of brain disease in COVID-19 and Dr Ben Michael will talk about spectrum, risk factors, and outcomes of neurological and psychiatric complications of COVID-19. 



Click here to view this webinar in full screen

Neurological Associations of COVID-19: Olfactory transmucosal invasion and psychosis risk

17/02/2021

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, we will present latest data on olfactory transmucosal SARS-CoV-2 invasion, and discuss COVID-19 and psychosis risk.


Click here to view this webinar in full screen. 

Neurological Associations of COVID-19: A Russian perspective and data from the ALBACOVID

12/01/2021

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, we will present data from a retrospective, observational study from hospitalised patients in Spain and a Russian perspective on COVID-neuro. We will also have a brief literature digest from @Neuropsychcovid and an introduction by the WHO Clinical Exchange Network.

Find out more about the COVID-19 Neuro Network


Click here to view this webinar in full screen. 

Neurological Associations of COVID-19: Pooling global data on NeuroCOVID

11/12/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, it is all about pooling global data on NeuroCOVID. Leads of the European Academy of Neurology (EAN) Neurocovid Registry and the Global Consortium Study (GCS) of Neurological Dysfunction in COVID-19 will present their registries. We will also present first data from the COVID-Neuro Network’s global meta-analysis of individual patient data on neurological associations of COVID-19. We will also have a brief literature digest from @Neuropsychcovid.


Click here to view this webinar in full screen. 

Neurological Associations of COVID-19: Neuro COVID-19 in India and encephalitis lethargica

05/11/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are frequent. In this episode, we will discuss COVID-neuro cases from India and encephalitis cases from the UK. We will also have a brief literature digest from @Neuropsychcovid.


Click here to view this webinar in full screen. 

Neurological Associations of COVID-19: Study results from COPING and CoCo-Neuro

27/10/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, we will present results from two studies from the UK and France. The COPING study assesses the impact of the novel coronavirus (COVID-19) pandemic on mental and neurological health, and how different factors associated with the virus are affecting the population. The CoCo-Neuro study characterises the neurological and psychiatric manifestations occurring in the context of Covid-19 infection and aims to improve clinical management, rehabilitation and follow-up.


Click here to view this webinar in full screen. 

Webinar: Neurological disorders associated with COVID-19: Learnings from the current literature and 'mutant' responses to COVID-19

10/09/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. In this episode, we will discuss what we can learn from the literature on neurological manifestations of COVID-19 and 'mutant' responses to COVID-19.


Click here to view this webinar in full screen. 

Neurological disorders associated with COVID-19: Neuropsychiatric and neurocognitive aspects in Australia and America

20/08/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. In this episode, we will review neuropsychiatric manifestations of COVID-19, and hear some preliminary results on the impact of COVID-19 on neurocognition and olfaction.


Click here to view this webinar in full screen. 

Neurological disorders associated with COVID-19: The Known and Unknown, and special focus on Alzheimer's dementia

02/07/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. In this episode, we will review complications of COVID-19 in patients with Alzheimer’s disease, as well as get some more insights into what’s known and unknow about Neurological Conditions in the Context of COVID-19.


Click here to view this webinar in full screen.

Neurological disorders associated with COVID-19: Guillain-Barré Syndrome Cases and Patients on Immunomodulators

 

09/06/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. After a successful first webinar, we will now review the first few cases of Guillain-Barré syndrome (GBS) following SARS-CoV-2 infection and discuss the management of patients on immunomodulators during the COVID-19 pandemic.

A workshop report is available here.


Click here to view this workshop in full screen. 

Neurological Disorders Associated with COVID-19

01/05/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. This webinar reviewed what’s known about neurological manifestations of SARS CoV-2 and related coronaviruses, consider the disease mechanisms and outline a framework for future investigative studies.

A workshop report is available here.